馬偕醫學院 Mackay Medical College
馬偕首頁｜意見交流｜網站導覽｜WEB MAIL｜個人PORTAL
｜搜尋： 搜尋
醫學院簡介 分隔線 學術單位 分隔線 行政單位 分隔線 最新消息 分隔線 招生資訊
馬偕醫學院 Mackay Medical College
師資陣容  
王豊裕
(Wang, Li-Yu)
職稱 教授
主要學歷

台灣大學公共衛生學系學士、碩士、博士
主要經歷

1.馬偕醫學院教授(2009.08迄今)
2.台北醫學大學教授
3.慈濟大學助理教授、副教授、教授
教學專長

生物統計學、流行病學研究法、資料處理與分析、研究規劃與設計、分子流行病學、環境流行病學
研究專長

流行病學研究、肝炎研究
學術期刊
  1. Wu YJ, Wu YJ, Chou CL, Cheng CF, Lu SX, Wang LY*.  Hemodynamic parameters and diabetes mellitus in community-dwelling middle-aged adults and elders: a community-based study. Scientific Reports. Vol.14(1):e12032. May. 2024. (SCI/SCIE)
  2. Chou CL, Liu CC, Wu TW, Cheng CF, Lu SX, Wu YJ, Wang LY*.  Predictability of cardiovascular risk scores for carotid atherosclerosis in community-dwelling middle-aged and elderly adults. Journal of Clinical Medicine. Vol.13(9):e2563. Apr. 2024. (SCI/SCIE) ( SDGs3)
  3. Tzu-Wei Wu, CHOU CL, Chen CF, Wang LY*.  Common genetic variants of response to hepatitis B vaccines correlate with risks of chronic infection of hepatitis B Virus: a community-based case-control study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Vol.24(11):e9741. Jun. 2023. (SCI/SCIE)
  4. Tzu-Wei Wu, CHOU CL, Lu SX, Cheng CF, Wang LY*.  Reply to "Is the relation between three comorbidities and carotid atherosclerosis dependent on the sum or not?". Journal of the Chinese Medical Association. Vol.86(6):615-616. Jun. 2023. (SCI/SCIE)
  5. Tzu-Wei Wu, Chao-Liang Chou, Chun-Fang Cheng, Shu-Xin Lu, Yih-Jer Wu, Li-Yu Wang*.  Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case-control study. Cardiovascular Diabetology. Vol.22-No.1:e51. Mar. 2023. (SCI/SCIE)
  6. Lu SX, Wu TW, Chou CL, Cheng CF, Wang LY*.  Combined effects of hypertension, hyperlipidemia, and diabetes mellitus on the presences and severity of carotid atherosclerosis in community-dwelling elders: a community-based study. Journal of the Chinese Medical Association. Vol.86:220-226. Feb. 2023. (SCI/SCIE)
  7. Lin TF, Chou CL, Hsieh CJ, Wu YJ, Chen YC, Wu TW, Lu SX, Juang YL, Wang LY*.  Association of Common Variants in OLA1 Gene with Preclinical Atherosclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Vol.23-No.19:e11511. Sep. 2022. (SCI/SCIE)
  8. Wu TW, Chou CL, Cheng CF, Lu SX, Wang LY*.  Prevalences of diabetes mellitus and carotid atherosclerosis and their relationships in middle-aged adults and elders: a community-based study. Journal of the Formosan Medical Association. Vol.121(6):1133-1140. Jun. 2022. (SCI/SCIE)
  9. Hu HH, Jeng WJ, Pan MH, Luo WS, Chang CL, Huang YT, Su CY, Chiang CT, Jen CL, Chien YC, Lu SN, Wang LY, Huang LR, Lee MH, Liu J, Nguyen MH, Chen CJ, Yang HI.  Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. Vol.55-No.5:558-567. Mar. 2022. (SCI/SCIE)
  10.  Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. Vaccine. Vol.37-No.43:6435-6440. Oct. 2019. (SCI)
  11.  Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection. Clinical Gastroenterology & Hepatology. Vol.17:1413-1415. Jun. 2019. (SCI)
  12.  Common Genetic Variants on Bone Morphogenetic Protein Receptor Type IB (BMPR1B) Gene Are Predictive for Carotid Intima-Media Thickness.. Circulation Journal. Vol.83:749-756. Mar. 2019. (SCI)
  13.  Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients. Clinical Gastroenterology Hepatology. Vol.17:172-181. Jan. 2019. (SCI)
  14.  Segment-specific prevalence of carotid artery plaque and stenosis in middle-aged adults and elders in Taiwan: a community-based study. Journal of the Formosan Medical Association. Vol.118:64-71. Jan. 2019. (SCI)
  15.  Associations of common genetic variants on IL-17 genes and carotid intima-media thickness. Journal of Atherosclerosis Thrombosis. Vol.25:1156-1167. Nov. 2018. (SCI)
  16. Lin YJ, Chang CL, Chen LC, Hu HH, Liu J, Korenaga M, Huang YH, Jen CL, Su CY, Nishida N, Sugiyama M, Lu SN, Wang LY, et al.  A Glycomarker for short-term prediction of hepatocellular carcinoma: a longitudinal study with serial measurements. Clinical and Translational Gastroenterology. Vol.9:183-183. Sep. 2018. (SCI)
  17. Wu TW, Liu CC, Hung CL, Yen CH, Wu YJ, Wang LY, Yeh HI.  Genetic profiling of young and aged endothelial progenitor cells in hypoxia. Plos One. Vol.13:19657-19657. Apr. 2018. (SCI)
  18. Chu YJ, Yang HI, Wu HC, Lee MH, Liu J, Wang LY, Lu SN, Jen CL, You SL, Santella RM, Chen CJ.  Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. European Journal Cancer. Vol.94:37-46. Mar. 2018. (SCI)
  19. Chen WC, Chung CH, Lu YC, Wu MH, Chou PH, Yen JY, Lai YW, Wang GS, Liu SC, Cheng JK, Wu YJ, Yeh HI, Wang LY, Wang SW.  BMP-2 induces angiogenesis by provoking integrin α6 expression in human endothelial progenitor cells. Biochemical Pharmacology. Vol.150:256-266. Feb. 2018. (SCI)
  20. Hung CL, Chang SC, Chang SH, Chi PC, Lai YJ, Wang SW, Wu YJ, Yeh HI, Lin SJ, Chen CH, Mochly-Rosen D, Wang LY, et al.  Genetic polymorphisms of alcohol metabolizing enzymes and alcohol consumption are associated with asymptomatic cardiac remodeling and subclinical systolic dysfunction in large community-dwelling Asians. Alcohol and Alcoholism. Vol.52:638-646. Nov. 2017. (SCI)
  21. Liu J, Hu HH, Lee MH, Korenaga M, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, et al..  Serum levels of M2BPGi as short-term predictors of hepatocellular carcinoma in untreated chronic hepatitis B patients. Scientific Reports. Vol.7:14352-14352. Oct. 2017. (SCI)
  22. Lai TS, Lee MH, Yang HI, You SL, Lu SN, Wang LY, Yuan Y, L’Italien G, Chien KL, Chen CJ, et al..  High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease. Kidney International. Vol.92:703-709. Sep. 2017. (SCI)
  23. Lai TS, Lee MH, Yang HI, You SL, Lu SN, Wang LY, et al..  Hepatitis C Viral Load, Genotype, and Increased Risk of Developing End-stage Renal Disease: REVEAL-HCV Study. Hepatology. Vol.66:784-793. Sep. 2017. (SCI)
  24. Chu YJ, Yang HI, Wu HC, Liu J, Wang LY, Lu SN, Lee MH, Jen CL, et al..  Aflatoxin B(1) exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. International Journal of Cancer. Vol.141:711-720. Aug. 2017. (SCI)
  25. Wu TW, Hung CL, Liu CC, Wu YJ, Wang LY*, Yeh HI.  Associations of cardiovascular risk factors with carotid intima-media thickness in middle-age adults and elders. Journal of Atherosclerosis and Thrombosis. Vol.24:677-686. Jul. 2017. (SCI)
  26. Huang CF, Yeh ML, Huang CI, Lin YJ, Tsai PC, Lin ZY, Chan SY, et al, Wang LY, et al..  Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance. Oncotarget. Vol.8:43925-43933. Jul. 2017. (其它地區具同儕審核機制之期刊)
  27. Lin YJ, Shaw TG, Yang HI, Lu SN, Jen CL, Wang LY, Wong KH, Chan SY, et al..  Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study. Liver International. Vol.37:179-186. Feb. 2017. (SCI)
  28. Chien J, Liu J, Lee MH, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, et al.  Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis. J Gastroenterol Hepatol. Vol.31:1971-1977. Dec. 2016. (SCI)
  29. Hu HH, Liu J, Lin YL, Luo WS, Chu YJ, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, et al.  The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut. Vol.65:1514-1521. Sep. 2016. (SCI)
  30. Liu J, Yang HI, Lee MH, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, et al..  Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.. Hepatology. Vol.64:381-389. Aug. 2016. (SCI)
  31. Liu J, Yang HI, Lee MH, Jen CL, Hu HH, Lu SN, Wang LY, et al.  Alcohol drinking mediates the association between polymorphisms of ADH1B and ALDH2 and hepatitis B-related hepatocellular carcinoma. Cancer Epidemiology, Biomarkers, and Prevention. Vol.25:693-699. Apr. 2016. (SCI)
  32. Hsiao KL, Wang LY, Lin CL, Liu HF.  New phylogenetic groups of Torque Teno Virus identified in eastern Taiwan indigenes. PLoS One. Vol.11:14990-14990. Feb. 2016. (SCI)
  33. Lee MH, Yang HI, Lu SN, Lin YJ, Jen CL, Wong KH, Chan SY, Chen LC, Wang LY, L’Italien G, Yuan Y, Chen CJ.  Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk. Scientific Reports. Vol.5:17030-17030. Nov. 2015. (SCI)
  34. Chen YC, Hsu KH, Chiou HY, Juang YL, Wu TW, Hung CL, Liu CC, Wu YJ, Yeh HI, Wang LY*.  Associations of lipid-related genetic markers with elevated carotid intima-media thickness in middle-age adults and elders. International Journal of Cardiology. Vol.189:264-266. Apr. 2015. (SCI)
  35. Liu J, Tseng TC, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, et al..  Predicting HBsAg Seroclearance in HBeAg-negative Chronic Hepatitis B Patients: External Validation of a Scoring System. J Infect Dis. Vol.211:1566-1570. Mar. 2015. (SCI)
  36. Wu TW, Chen CF, Lai SK, Lin HH, Chu CC, Wang LY*.  SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination-results of a genome-wide association study. J Gastroenterol Hepatol. Vol.30:891-899. Mar. 2015. (SCI)
  37. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, Wang LY, You SL, Hsiao CK, Chen PJ,  Chen CJ.  Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. GUT. Vol.63:1648-1657. Oct. 2014. (SCI)
  38. Hsu WL, Chien YC, Chiang CJ, Yang HI, Lou PJ, Wang CP, Yu KJ, You SL, Wang LY, et al..  Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette. Int J Cancer. Vol.135:1480-1486. Sep. 2014. (SCI)
  39. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, et al..  Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer. Vol.135:1119-1126. Sep. 2014. (SCI)
  40. Wu TW, Chan HL, Hung CL, Lu IJ, Wang SD, Wang SW, Wu YJ, Wang LY*, et al.  Differential patterns of effects of age and sex on metabolic syndrome in Taiwan: implication for the inadequate internal consistency of the current criteria. Diabetes Res Clin Pract. Vol.105:239-244. Aug. 2014. (SCI)
  41. Chen CL, Yang WS, Yang HI, Chen CF, You SL, Wang LY, et al..  Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in Taiwan. Cancer Epidemiol Biomarkers Prev. Vol.23:1659-1671. Aug. 2014. (SCI)
  42. Chuang FC, Liu HT, Wang LY, Kuo HC.  Overactive Bladder Changes with Time: A 5-Year Longitudinal Followup of Changes in Overactive Bladder Symptoms, Urodynamic Studies and Urinary Nerve Growth Factor Levels.. J Urol. Vol.192:458-463. Aug. 2014. (SCI)
  43. Liu J, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, et al..  Distinct seromarkers predict different milestones of chronic hepatitis B progression. Hepatology. Vol.61:77-86. Jul. 2014. (SCI)
  44. Lee MH, Lu SN, Yuan Y, Yang HI, Jen CL, You SL, Wang LY, et al..  Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies. PLoS One. Vol.9:94760-94760. May. 2014. (SCI)
  45. Wang CC, Hsieh TC, Tseng TC, Wang PC, Hsu CS, Lin HH, Wang LY, Kao JH.  Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis. J Formos Med Assoc. Vol.113:249-254. Feb. 2014. (SCI)
  46. Chen JH, Wang HY, Lin HH, Wang CC, Wang LY*.  Prevalence and determinants of gastroesophageal reflux symptoms in adolescents.. Journal of Gastroenterology and Hepatology. Vol.29:269-275. Feb. 2014. (SCI)
  47. Wu TW, Chu CC, Chang Liao HW, Lin SK, Ho TY, Lin M, Lin HH, Wang LY*.  HLA-DPB1 and anti-HBs titers kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy. Genes and Immunity. Vol.15:47-53. Jan. 2014. (SCI)
  48. Wu TW, Lin HH, Wang LY*.  When and for whom should booster hepatitis B vaccination be recommended?. Hepatology. Vol.59:349-350. Jan. 2014. (SCI)
  49. Loomba R, Liu J, Yang HI, Lee MH, Lu SN, Wang LY, Iloeje UH, You SL, Brenner D, Chen CJ.  Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma. Clinical Gastroenterology & Hepatology. Vol.11:1636-1645. Dec. 2013. (SCI)
  50. Wu TW, Chu CC, Ho TY, Chang Liao HW, Lin SK, Lin M, Lin HH, Wang LY*.  Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents.. Human Genetics. Vol.132:1131-1139. Oct. 2013. (SCI)
  51. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ.  Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles. Hepatology. Vol.58:545-554. Aug. 2013. (SCI)
  52. Ko CF, Lin NT, Chiou CS, Wang LY, Liu MC, Yang CY, Lee YS.  Infrequent cross-transmission of Shigella flexneri 2a strains among villages of a mountainous township in Taiwan with endemic shigellosis. BMC Infectious Diseases. Vol.13:354-354. Jul. 2013. (SCI)
  53. Liu J, Lee MH, Batrla-Utermann R, Jen CL, Iloeje UH, Iloeje UH, Wang LY, You SL, Hsiao CK, Yang HI, Chen CJ.  A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.. Journal of Hepatology. Vol.58:853-860. May. 2013. (SCI)
  54. Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Liu J, Chen CJ.  Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients. PLoS One. Vol.8:61448-61448. Apr. 2013. (SCI)
  55. Chiang CH, Yang HI, Jen CL, Lu SN, Wang LY, You SL, Su J, Iloeje UH, Chen CJ.  Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond). Vol.37:410-415. Mar. 2013. (SCI)
  56. Ko CF, Wang LY, Lin NT, Chiou CS, Yeh HC, Renn JH, Lee YS.  Transmission and strain variation of Shigella flexneri 4a after mass prophylaxis in a long-stay psychiatric centre. Epidemiology & Infection. Vol.141:242-250. Feb. 2013. (SCI)
  57. Wu TW, Lin HH, Wang LY*.  Chronic hepatitis B infection in adolescents who had received primary infantile vaccination.. Hepatology. Vol.57:38-45. Jan. 2013. (SCI)
  58. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, Wang CH, Chen WJ, Chen CJ, REVEAL-HCV Study Group.  Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study. J Infect Dis. Vol.206:469-477. Aug. 2012. (SCI)
  59. Yang HI, Hung HL, Lee MH, Liu J, Jen CL, Su J, Wang LY, Lu SN, You SL, Iloeje UH, Chen CJ.  Incidence and Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B. Clin Gastroenterol Hepatol. Vol.105:527-534. May. 2012. (SCI)
  60. Hung CL, Wu YJ, Liu CC, Chi BC, Chang SS, Wang LY*, Yeh HI, Wei YH.  Rationale and design of MAGNET (Mitochondria-AGing in NorthErn Taiwan) study: a community-based cohort investigating mitochondria-related aging and cardiovascular diseases in suburban areas of northern Taiwan.. Intl J Gerontology. Vol.6:122-126. Feb. 2012. (SCI)
  61. Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Chen CJ.  Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma. Gastroenterology. Vol.140-No.4:1240-1248. Oct. 2011. (SCI)
  62. Lee MH, Yang HI, Jen CL, Lu SN, Yeh SH,  Liu CJ, You SL, Sun CA, Wang LY, Chen WJ, Chen CJ.  Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991-2.. Gut. Vol.60-No.5:688-694. May. 2011. (SCI)
  63. Lee MH, Yang HI, Lu SN, Jen CL, Yeh SH, Liu CJ,  Chen PJ, You SL, Wang LY, Chen WJ, Chen CJ.  Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. Journal of Clinical Oncology. Vol.28-No.30:4587-4593. Oct. 2010. (SCI)
  64. Ho SC, Wang LY, Ho CK, Yang CY.  Fatal Occupational injuries in Taiwan: 1994-2005. Occup Environ Med. Vol.67:251-255. Jan. 2010. (SCI)
  65. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ.  Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the R.E.V.E.A.L.-HBV cohort study.. Liver Int. Vol.10:423-429. Jan. 2010. (SCI)
  66. Kuo HW, Chen PS, Ho SC, Wang LY, Yang CY.  Trihalomethanes in drinking water and the risk of death from rectal cancer: does hardness in drinking water matter?. J Toxicol Environ Health A.. Vol.73-No.12:807-818. Jan. 2010. (SCI)
  67. Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ.  for the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (the REVEAL-HBV) Study Group. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology. Vol.138-No.5:1747-1754. Jan. 2010. (SCI)
  68. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ.  R.E.V.E.A.L.-HBV Study Group. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology. Vol.139:474-482. Jan. 2010. (SCI)
  69. Wang CC, Lin SK, Tseng YF, Hsu CS, Tseng TC, Lin HH, Wang LY, Kao JH.  Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. Vol.24-No.8:1315-1317. Aug. 2009. (SCI)
  70. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ, Santella RM.  Aflatoxin B1 exposure, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Epidemiology Biomarkers Prevention. Vol.18:846-893. Mar. 2009. (SCI)
  71. Fu CC, Chen MC, Li YM, Liu TT, Wang LY.  The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.. Annals Academy of Medicine Singapore. Vol.38-No.1:15-21. Jan. 2009. (SCI)
  72. Yang HI, Yeh SH, Chen PJ,  Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ.  Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. Journal of the National Cancer Institute. Vol.100:1134-1143. Aug. 2008. (SCI)
  73. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, Chen CJ.  Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. Vol.135:111-121. Jul. 2008. (SCI)
  74. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ, Santella RM.  Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis. Vol.29:971-976. May. 2008. (SCI)
研討會
  1. Chang CL, Chen LC, Hu HH, Lin YJ, Liu J , Jen CL, Su CY, Chiang CT, Yuan Y , Lu SN, Wang LY, et al..  Serum Levels of Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein as a Time-Dependent Predictor of Hepatocellular Carcinoma in Chronic Hepatitis C Patients. 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). Nov. 2016.
  2. Hu HH, Chang CL, Liu J , Jen CL, Luo WS, Lin YL, Su CY, Chiang CT , Lee MH, Lu SN, Wang LY, Korenaga M , Mizokami M, Chen CJ, Yang HI.  WFA(+-)M2BP as a predictor of hepatocellular carcinoma in individuals who were seronegative for both HBV surface antigen and anti-HCV antibody. 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). Nov. 2016.
  3. Chen CF, Yang HI , Chang HC, Liu J, Lee MH, Jen CL, Wang LY, You SL, Lu SN, Chen CJ.  Higher Serum Testosterone Is Associated With Increased Risk of Liver Cirrhosis In Chronic Hepatitis B: The REVEAL-HBV Study. 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tra. May. 2016.
  4. Hu HH, Liu J, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, et al.  Baseline quantitative hepatitis B core antibodies can predict HBV DNA and HBsAg seroclearance in treatment-naïve HBeAg negative chronic hepatitis B patients. The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeti. Nov. 2015.
  5. Lee MH, Chang CL, Liu J, Hu HH, Jen CL, Lu SN, Wang LY, et al.  Serum Quantitative Levels of Hepatitis B Virus Core Antibody and Risk of Liver Cirrhosis and Hepatocellular Carcinoma-the R.E.V.E.A.L.-HBV Study. The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeti. Nov. 2015.
  6. Li-Yu Wang*, Hsin-Lung Chan, Po-Ching Chi, Chung-Lieh Hung, Chun-Chieh Liu, Tzu-Wei Wu, Yih-Jer Wu, Shwun-De Wang, Shih-Wei Wang, Hung-I Yeh.  Associations of intima-media thickness of different segments of carotid arteries and prevalent cardio-metabolic diseases in middle-age adults and elders in Taiwan. American Heart Association's 2015 Scientific Section. Nov. 2015.
  7. Liu HJ, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, et al .  Hepatitis B surface antigen and DNA levels can identify inactive carriers and predict lower risk for hepatocellular carcinoma and cirrhosis among genotype B and C chronic hepatitis B carriers. The International Liver Congress 2015. Apr. 2015.
  8. Liu L, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, et al.  Trajectories of hepatitis B surface antigen and associations with hepatocellular carcinoma, liver cirrhosis, and HBsAg seroclearance among chronic hepatitis B carriers with low viral loads. The International Liver Congress 2015. Apr. 2015.
  9. Hu HH, Liu J, Lin YL, Luo WS, Chu YJ, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, et al.  Association of single nucleotide polymorphism rs2296651 in SLC10A1 with hepatocellular carcinoma and liver cirrhosis. The International Liver Congress 2015. Apr. 2015.
  10. Chien JD, Liu J, Lee MH, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, et al.  Risk predictors of hepatocellular carcinoma among cirrhotic patients chronically infected with hepatitis B. The International Liver Congress 2015. Apr. 2015.
  11. Lin HH, Wang LY.  Hepatitis among Indigenous People in Taiwan. World Indigenous Peoples' Conference on Viral Hepatitis & 9th Australasian Viral Hepatitis Conferenc. Sep. 2014.
  12. Liu J, Yang HI, Chen CF, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, et al..  Serum levels of hepatitis B surface antigen predict long-term trajectories of hepatitis B viral load. International Liver Congress /49th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2014.
  13. Liu J, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL.  Risk predictors for liver cancer and cirrhosis among chronic hepatitis B patients with undetectable hepatitis B viral loads. International Liver Congress /49th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2014.
  14. Shaw GTW, Lee MH, Yang HI, Jen CL, Lu SN, Wang LY, et al..  Hepatitis c virus infection and the associated risk for diabetes mellitus. International Liver Congress /49th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2014.
  15. Lee MH, Yang HI, Lu SN, Lin YJ, Liu PJ, Chien YC, Jen CL, You SL, Wang LY, Yuan Y, L’Italien G, Chen CJ.  Population-Based Genome-Wide Association Study to Identify Potential Single Nucleotide Polymorphisms Associated with the Serum Levels of Alanine Aminotransferase among Asymptomatic Chronic Hepatitis C Patients.. The 64th Annual Meeting of the American Association for the Study of Liver Diseases. Nov. 2013.
  16. Lee MH, Yuan Y, Yang HI, Lu SN, Lin YJ, Liu PJ, Chien YC, Jen CL, Jen CL, Wang LY, L'Italien G, Chen CJ.  Genome-Wide Association Study To Identify Potential Single Nucleotide Polymorphisms Associated With Spontaneous Hepatitis C Virus Clearance Among Chronic Hepatitis C Patients. International Liver Congress /48th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2013.
  17. Liu J, Yang HI, Lee MH, Jen CL, Lu SN, Wang LY, You SL, Iloeje UH, Hsiao CK, Chen CJ.  Seroclearance of hbvdna predicts significantly reduced risk of hepatocellular carcinoma among those with high viral loads: a time-dependent analysis of serially measured biomarkers.. International Liver Congress /48th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2013.
  18. Liu J, Yang HI, Lee MH, Jen CL, Lu SN, Wang LY, You SL, Iloeje UH, Hsiao CK, Chen CJ.  Quantitative serum hepatitis b surface antigen improves predictability of HBV DNA seroclearance but not HBeAg seroclearance in chronic hepatitis B patients. International Liver Congress /48th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2013.
  19. Shaw GTW, Lee MH, Yuan Y, Yang HI, Lin YJ, Jen CL, Lu SN, Wang LY, You SL, L'Italien G, Chen CJ.  Host genetic variants around IL28a/IL28b associated with HCV-related outcomes based on REVEAL-HCV cohort. International Liver Congress /48th Annual Meeting of the European-Association-for-the-Study-of-the-L. Apr. 2013.
  20. Liu J, Lee MH, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, Wang LY, You SL, Hsiao KC, Yang HI,, Chen CJ.  Differences in the role of quantitative hepatitis B surface antigen between HBeAg seropositive and seronegative individuals with chronic hepatitis B. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). Apr. 2012.
  21. Lee MH, Lu SN, Yang HI, Jen CL, You SL, Wang LY, Yuan Y, Litalien G, Chen CJ.  Development and validation of prediction models for risk of hepatocellular carcinoma among hepatitis C virus infected patients. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). Apr. 2012.
  22. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Su J, Lu SN, You SL, Wang LY, Chen CJ.  Development of prediction models for HBV-related liver cirrhosis by integarting HBV genotype and serum levels of HBV DNA and HBsAg. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). Apr. 2012.
  23. Chen CJ, Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, loeje UH, Su J, Lu SN, You SL, Wang LY.  Integrating quantitiative serum HBsAg levels into risk scores for predicting hepatocellular carcinoma in chronic hepatitis B patients. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). Apr. 2012.
  24. Chen CF, Yang H, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Lee WC, Chen CJ.  Prediction of liver cirrhosis risk by long-term changes in serum levels of HBV DNA and alanine aminotransferase. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). Apr. 2012.
  25. Chen CJ, Lee MH, Liu J, Batrla-Utermann R, Jen CL, Iloeje U, Lu SN, Wang LY, You SL, Yang HI..  uantitative serum levels of hepatitis B virus DNA and surface antigen are independent risk predictors of hepatocellular carcinoma.. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). Nov. 2011.
  26. Liu J, Lee MH, Batrla-Utermann R, Jen CL, Iloeje U, Lu SN, Wang LY, You SL, Hsiao KC, Yang HI, Chen CJ.  Quantitative hepatitis b surface antigen levels are significant independent predictors of HBV DNA and HBsAg seroclearance in chronic hepatitis B. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). Nov. 2011.
  27. Wang LY*, Hung CL, Yeh HI, Wei YH, the Mitochondria-Aging Study Group.  Setup a community-based adult cohort for the researches on aging-related disorders: preliminary results of health screening. 2011 Mackay International Symposium on Mitochondrial Medicine in Human Health and Diseases. Jul. 2011.
  28. Wang LY*, Lin HH.  Chronic HBV infection in adolescents who were born after the start of universal hepatitis B vaccination program. 2011 Mackay International Symposium on Mitochondrial Medicine in Human Health and Diseases. Jul. 2011.
  29. Wang LY*, Lin HH.  Short-term effects of a booster dose of hepatitis B vaccine in anti-HBs-negative adolescents who had received primary infantile HB vaccination 16 years ago. 2011 Mackay International Symposium on Mitochondrial Medicine in Human Health and diseases.. Jul. 2011.
  30. Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Chen CJ.  Conventional seromarkers for prediction of hepatitis B virus-associated hepatocellular carcinoma: an easy-to-use risk score. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). Apr. 2011.
  31. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ.  Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based long-term follow-up study. 45th Annual Meeting of the European-Association-for-the-Study-of-Liver. Apr. 2010.
  32. Lee MH, Yang HI, Lu SN, Jen CL, Yeh SH, Liu CJ, Chen PJ, You SL, Wang LY, Chen WJ, Chen CJ.  Seromarkers for long-term prediction of hepatocellular carcinoma risk in patients with chronic hepatitis C. 45th Annual Meeting of the European-Association-for-the-Study-of-Liver. Apr. 2010.
計畫
計畫起訖年月計畫名稱擔任職務
2024-08~2025-07校外研究計畫獎助款(B)_MMC-RD-113-1B-P008_王豊裕主持人
2023-08~2024-07校外研究計畫獎助款(B)_MMC-RD-112-1B-P012_王豊裕主持人
2023-08~2026-07探討心血管-代謝症侯群之基因與非基因危險因子(II)：社區動脈粥狀硬化風險追蹤研究主持人
2022-08~2023-07校外研究計畫獎助款(B)_MMC-RD-111-1B-P007_王豊裕主持人
2022-08~2023-07探討心血管-代謝症侯群之基因與非基因危險因子：(II) 社區動脈粥狀硬化風險追蹤研究主持人
2021-08~2022-07校外研究計畫獎助款(B)_MMC-RD-110-1B-P010_王豊裕主持人
2020-08~2021-07校外研究計畫獎助款(B)_1091B03_王豊裕主持人
2019-08~2020-07校外計畫獎助款_王豊裕_1081B15主持人
2019-08~2022-07動脈粥狀硬化及心血管疾病之基因研究：I、確認經全基因體相關研究篩選之動脈粥狀硬化候選基因標記的影響主持人
2018-10~2019-09大學招生專業化發展試辦計畫主持人
2018-08~2019-07頸動脈粥狀硬化及心血管疾病之基因研究：I、確認經全基因體相關研究篩選之頸動脈粥狀硬化候選基因標記的影響(科技部專題研究計畫主持人
2018-08~2019-07校外研究計畫獎助款_王豊裕_1071B18主持人
2018-08~2019-07頸動脈粥狀硬化及心血管疾病之基因研究：I、確認經全基因體相關研究篩選之頸動脈粥狀硬化候選基因標記的影響主持人
2017-08~2018-07校外研究計畫獎助款_王豊裕_1061B10主持人
2016-08~2017-07校外研究計畫獎助款_王豊裕 _1051B07主持人
2015-08~2018-07B型肝炎疫苗反應性之全基因體相關研究: 強調人類白血球抗原相關基因的影響(A genome-wide association study on responsiveness to hepatitis B vaccination: focus on the influences of human leukocyte antigen loci)主持人
2015-08~2018-07B型肝炎疫苗反應性之全基因體相關研究: 強調人類白血球抗原相關基因的影響(2/3)主持人
2014-08~2015-07B型肝炎疫苗反應性之全基因體相關研究: 強調人類白血球抗原相關基因的影響(第二年)主持人
2013-08~2014-07B型肝炎疫苗反應性之全基因體相關研究: 強調人類白血球抗原相關基因的影響主持人
2010-08~2013-07探討老化相關疾病之決定因素及機轉：強調粒線體失能的影響主持人
2008-08~2011-07探討全面性B型肝炎疫苗接種計畫實施後之出生世代HBV感染原因主持人
組織
擔任期間機構職務
2017-11-01 ~
2020-10-31		台灣流行病學學會常務理事
2014-11-01 ~
2017-10-31		台灣流行病學學會常務理事
2014-03-21 ~
2016-04-16		Asia-Pacific Organization for Cancer PreventionExecutive member & Regional Chairperson
2010-10-01 ~
2012-10-01		台灣公共衛生學會理事(第十七屆)
2009-10-01 ~
2012-10-01		台灣流行病學學會秘書長
編審
期間期刊名稱性質
2009-01-01 ~
2017-12-31		Tzu Chi Med J編輯委員
榮譽獎
  1. 1996年美洲癌症研究學會(American Association on Cancer Research) Young Investigator Research Award.
  2. 88學年度國科會甲種研究獎勵
  3. 慈濟大學92學年度優良論文獎
  4. 慈濟大學94學年度優良論文獎
  5. 慈濟大學96學年度優良論文獎
個人興趣

與家人一起、閱讀、旅遊
聯絡方式

yannbo@mmc.edu.tw
回上頁
馬偕醫學院 醫學系 MacKay Medical College Department of Medicine
辦公位址：新北市三芝區中正路三段46號 教學大樓B棟五樓
電話：(02)26360303 #1201　電子郵件：cindy@mmc.edu.tw
設計、製作、維護